{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T06:26:22Z","timestamp":1793600782957,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009009","name":"Novartis Pharmaceuticals Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jid.2026.03.016","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:35:44Z","timestamp":1774658144000},"page":"2475-2485.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cellular and molecular landscape of early hidradenitis suppurativa lesions reveals early immune microenvironment"],"prefix":"10.1016","volume":"146","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2831-5579","authenticated-orcid":false,"given":"Stephan M.","family":"Caucheteux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9113-0430","authenticated-orcid":false,"given":"Saeed","family":"Khalili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4637-2291","authenticated-orcid":false,"given":"David","family":"Croitoru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-7410-6461","authenticated-orcid":false,"given":"Lily","family":"Acheampong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0080-0812","authenticated-orcid":false,"given":"Johann E.","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6079-4517","authenticated-orcid":false,"given":"Vincent","family":"Piguet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jid.2026.03.016_bib1","first-page":"1234","article-title":"Clinical characteristics of a Canadian cohort of hidradenitis suppurativa","volume":"4","author":"Acheampong","year":"2025","journal-title":"J Eur Acad Dermatol Venereol Clin Pract"},{"key":"10.1016\/j.jid.2026.03.016_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17204-5","article-title":"QuPath: open source software for digital pathology image analysis","volume":"7","author":"Bankhead","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.jid.2026.03.016_bib3","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5908","article-title":"Neutrophil extracellular traps, B cells, and type I interferons contribute to immune dysregulation in hidradenitis suppurativa","volume":"11","author":"Byrd","year":"2019","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jid.2026.03.016_bib4","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jid.2021.07.187","article-title":"Autoantibodies present in hidradenitis suppurativa correlate with disease severity and promote the release of proinflammatory cytokines in macrophages","volume":"142","author":"Carmona-Rivera","year":"2022","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jid.2024.04.037","article-title":"Hidradenitis suppurativa tunnels invasive transcriptional signature","volume":"145","author":"Caucheteux","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib6","first-page":"12.47.1","article-title":"Staining of frozen and formalin-fixed, paraffin-embedded tissues with metal-labeled antibodies for imaging mass cytometry analysis","volume":"82","author":"Chang","year":"2017","journal-title":"Curr Protoc Cytom"},{"key":"10.1016\/j.jid.2026.03.016_bib7","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.jid.2024.08.039","article-title":"Imaging mass cytometry in psoriatic disease reveals immune profile heterogeneity in skin and synovial tissue","volume":"145","author":"Eder","year":"2025","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib8","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/bjd.17426","article-title":"Complement, hidradenitis suppurativa and pathogen-driven positive selection","volume":"180","author":"Frew","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jamadermatol.2025.4652","article-title":"Standardization of lesion classification and assessment by investigators in clinical trials for hidradenitis suppurativa: a consensus exercise using a modified Delphi approach","volume":"162","author":"Garg","year":"2026","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139930","article-title":"Contribution of plasma cells and B cells to hidradenitis suppurativa pathogenesis","volume":"5","author":"Gudjonsson","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2026.03.016_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","article-title":"Dictionary learning for integrative, multimodal and scalable single-cell analysis","volume":"42","author":"Hao","year":"2024","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jid.2026.03.016_bib12","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1111\/bjd.16101","article-title":"Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa","volume":"178","author":"Ingram","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib13","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/bjd.13866","article-title":"Management of hidradenitis suppurativa: a U.K. survey of current practice","volume":"173","author":"Ingram","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib14","first-page":"CD010081","article-title":"Interventions for hidradenitis suppurativa","volume":"2015","author":"Ingram","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jid.2026.03.016_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.semcdb.2022.01.006","article-title":"Advances in molecular pathogenesis of hidradenitis suppurativa: dysregulated keratins and ECM signaling","volume":"128","author":"Kashyap","year":"2022","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.jid.2026.03.016_bib16","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0140-6736(23)00022-3","article-title":"Secukinumab in moderate-to-severe hidradenitis suppurativa (SUNSHINE and SUNRISE): week 16 and week 52 results of two identical, multicentre, randomised, placebo-controlled, double-blind phase 3 trials","volume":"401","author":"Kimball","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2026.03.016_bib17","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1016\/S0140-6736(24)00101-6","article-title":"Efficacy and safety of bimekizumab in patients with moderate-to-severe hidradenitis suppurativa (BE HEARD I and BE HEARD II): two 48-week, randomised, double-blind, placebo-controlled, multicentre phase 3 trials","volume":"403","author":"Kimball","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jid.2026.03.016_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa1504370","article-title":"Two phase 3 trials of adalimumab for hidradenitis suppurativa","volume":"375","author":"Kimball","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jid.2026.03.016_bib19","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bjd\/ljad345","article-title":"Hidradenitis suppurativa: new insights into disease mechanisms and an evolving treatment landscape","volume":"190","author":"Krueger","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib20","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.169870","article-title":"Tertiary lymphoid structures sustain cutaneous B cell activity in hidradenitis suppurativa","volume":"9","author":"Lowe","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.jid.2026.03.016_bib21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1001\/jamadermatol.2019.0759","article-title":"Depression and anxiety in adults with hidradenitis suppurativa: a systematic review and meta-analysis","volume":"155","author":"Machado","year":"2019","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib22","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1038\/s41467-022-30033-z","article-title":"Reference-free cell type deconvolution of multi-cellular pixel-resolution spatially resolved transcriptomics data","volume":"13","author":"Miller","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.jid.2026.03.016_bib23","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jid.2019.08.453","article-title":"Enrichment of plasma cells in the peripheral blood and skin of patients with hidradenitis suppurativa","volume":"140","author":"Musilova","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib24","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.4049\/jimmunol.167.4.1857","article-title":"Cutting edge: T cell migration regulated by CXCR4 chemokine receptor signaling to ZAP-70 tyrosine kinase","volume":"167","author":"Ottoson","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.jid.2026.03.016_bib25","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.jid.2024.02.030","article-title":"Advances in hidradenitis Suppurativa Pathogenesis and Therapies from the Symposium on HS Advances","volume":"144","author":"Park","year":"2024","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-020-0149-1","article-title":"Hidradenitis suppurativa","volume":"6","author":"Sabat","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jid.2026.03.016_bib27","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.jaci.2022.10.034","article-title":"Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa","volume":"151","author":"Sabat","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jid.2026.03.016_bib28","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jaad.2010.07.010","article-title":"Expression of the IL-23\/Th17 pathway in lesions of hidradenitis suppurativa","volume":"65","author":"Schlapbach","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib29","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1046\/j.1523-1747.2003.12563.x","article-title":"The molecular basis of lymphocyte recruitment to the skin: clues for pathogenesis and selective therapies of inflammatory disorders","volume":"121","author":"Sch\u00f6n","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jid.2026.03.016_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107523","article-title":"CytoMAP: a spatial analysis toolbox reveals features of myeloid cell organization in lymphoid tissues","volume":"31","author":"Stoltzfus","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.jid.2026.03.016_bib31","doi-asserted-by":"crossref","DOI":"10.1172\/JCI169225","article-title":"Single-cell sequencing reveals Hippo signaling as a driver of fibrosis in hidradenitis suppurativa","volume":"134","author":"van Straalen","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jid.2026.03.016_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/JCI186744","article-title":"Hidradenitis suppurativa: key insights into treatment success and failure","volume":"134","author":"van Straalen","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jid.2026.03.016_bib33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/bjd\/ljae098","article-title":"Secukinumab in patients with moderate-to-severe hidradenitis suppurativa based on prior biologic exposure: an efficacy and safety analysis from the SUNSHINE and SUNRISE phase III trials","volume":"190","author":"Zouboulis","year":"2024","journal-title":"Br J Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26010055?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X26010055?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:30:17Z","timestamp":1793597417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X26010055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022202X26010055"],"URL":"https:\/\/doi.org\/10.1016\/j.jid.2026.03.016","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular and molecular landscape of early hidradenitis suppurativa lesions reveals early immune microenvironment","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jid.2026.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of Society for Investigative Dermatology.","name":"copyright","label":"Copyright"}]}}